Key statistics
On Friday, Heron Therapeutics Inc (HRTX:NAQ) closed at 2.06, 312.00% above the 52 week low of 0.50 set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.02 |
---|---|
High | 2.06 |
Low | 1.93 |
Bid | 2.06 |
Offer | 2.09 |
Previous close | 2.02 |
Average volume | 1.79m |
---|---|
Shares outstanding | 151.67m |
Free float | 150.58m |
P/E (TTM) | -- |
Market cap | 306.37m USD |
EPS (TTM) | -0.3249 USD |
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
- Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
- Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
- Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024
- Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
- Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
More ▼